Literature DB >> 1525643

Cholinergic gating of response to auditory stimuli in rat hippocampus.

V Luntz-Leybman1, P C Bickford, R Freedman.   

Abstract

Rapid decrement of response to repeated stimuli is a characteristic of hippocampal neurons. To assess the possible role in this process of cholinergic afferents from the medial septal nucleus, a series of cholinergic antagonists were administered intraventricularly to chloral hydrate-anesthetized rats. Auditory stimuli were delivered in pairs to the rats, and the evoked response was recorded from an electrode in the CA3 layer of the hippocampus. The most prominent component of the auditory evoked potential recorded in this region (N40) showed over 60% decrement in the amplitude of the response to the second stimulus when the two stimuli were delivered 0.5 s apart. Only neuromuscular-type nicotinic antagonists, alpha-bungarotoxin and (+)-tubocurarine, disrupted this decrement of response to repeated auditory stimuli. The muscarinic antagonist, scopolamine, and the ganglionic-type nicotinic antagonists, kappa-bungarotoxin and mecamylamine, were without effect. The results suggest that a subset of nicotinic receptors mediate the gating of response to auditory stimuli in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525643     DOI: 10.1016/0006-8993(92)91437-j

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  61 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  Distinct neural generators of sensory gating in schizophrenia.

Authors:  Terrance J Williams; Keith H Nuechterlein; Kenneth L Subotnik; Cindy M Yee
Journal:  Psychophysiology       Date:  2010-08-23       Impact factor: 4.016

3.  Nicotine suppresses the P13 auditory evoked potential by acting on the pedunculopontine nucleus in the rat.

Authors:  N Mamiya; R Buchanan; T Wallace; R D Skinner; E Garcia-Rill
Journal:  Exp Brain Res       Date:  2005-03-08       Impact factor: 1.972

4.  Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice.

Authors:  R Paylor; M Nguyen; J N Crawley; J Patrick; A Beaudet; A Orr-Urtreger
Journal:  Learn Mem       Date:  1998 Sep-Oct       Impact factor: 2.460

Review 5.  Elevation of intracellular calcium levels in neurons by nicotinic acetylcholine receptors.

Authors:  M M Rathouz; S Vijayaraghavan; D K Berg
Journal:  Mol Neurobiol       Date:  1996-04       Impact factor: 5.590

Review 6.  The acetylcholine receptor ligand-gated channel as a molecular target of disease and therapeutic agents.

Authors:  F J Barrantes
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

7.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

Authors:  R Freedman; H Coon; M Myles-Worsley; A Orr-Urtreger; A Olincy; A Davis; M Polymeropoulos; J Holik; J Hopkins; M Hoff; J Rosenthal; M C Waldo; F Reimherr; P Wender; J Yaw; D A Young; C R Breese; C Adams; D Patterson; L E Adler; L Kruglyak; S Leonard; W Byerley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 8.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

9.  Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study.

Authors:  Merilyne C Waldo; Laurie Woodward; Lawrence E Adler
Journal:  Psychiatry Res       Date:  2009-12-02       Impact factor: 3.222

10.  Genetic Association Study of the Alpha 7 Nicotinic Receptor (CHRNA7) with the Development of Schizophrenia and Bipolar Disorder in Korean Population.

Authors:  Eun-Jeong Joo; Kyu Young Lee; Hyun Sook Kim; Se Hyun Kim; Yong Min Ahn; Yong Sik Kim
Journal:  Psychiatry Investig       Date:  2010-07-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.